Effect of Lissachatina fulica chitosan on the antioxidant and lipid profile of hypercholesterolemic male Wistar rats

Context: The increase in reactive oxygen species production in hypercholesterolemia can degrade polyunsaturated fatty acids and form malondialdehyde (MDA). There is a need for a natural alternative treatment, such as Lissachatina fulica chitosan. Aims: To analyze the potential of Lissachatina fulica...

Full description

Saved in:
Bibliographic Details
Main Authors: Umarudin (Author), Sri Widyarti (Author), Warsito (Author), Sri Rahayu (Author)
Format: Book
Published: GarVal Editorial Ltda., 2022-11-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_e99100e58db64dda9f578b8c3d19a9c7
042 |a dc 
100 1 0 |a Umarudin  |e author 
700 1 0 |a Sri Widyarti  |e author 
700 1 0 |a Warsito  |e author 
700 1 0 |a Sri Rahayu  |e author 
245 0 0 |a Effect of Lissachatina fulica chitosan on the antioxidant and lipid profile of hypercholesterolemic male Wistar rats 
260 |b GarVal Editorial Ltda.,   |c 2022-11-01T00:00:00Z. 
500 |a https://doi.org/10.56499/jppres22.1468_10.6.995 
500 |a 0719-4250 
520 |a Context: The increase in reactive oxygen species production in hypercholesterolemia can degrade polyunsaturated fatty acids and form malondialdehyde (MDA). There is a need for a natural alternative treatment, such as Lissachatina fulica chitosan. Aims: To analyze the potential of Lissachatina fulica chitosan in increasing the superoxide dismutase (SOD) level, reducing lipid profile, and MDA level of male Wistar rats with hypercholesterolemia model. Methods: The male Wistar rats were divided into six groups (n = 4): P0 (normal control); P1-P5 fed a high-fat diet for four weeks. P1 were treated with fed with a high-fat diet; P2 were treated with ezetimibe of 0.18 mg/200 g BW; P3, P4, and P5 Groups; fed with a high-fat diet and Lissachatina fulica chitosan of 100 mg, 200 mg, and 300 mg/200g BW, respectively. The lipid profile was conducted in rat blood samples by using the CHOP-PAP method, the MDA analysis using the TBARS test, and SOD assay analysis using a kit. Results: The results reveal that the treatment Lissachatina fulica chitosan (300 mg/200 g BW) was significantly effective (p<0.05) to decrease in total cholesterol level (96.7 ± 1.9 mg/dL), triglyceride (75.6 ± 1.6 mg/dL), LDL (29.8 ± 2.5 mg/dL), and MDA (1.2 ± 0.1 nmol/mL) as well as a significant increase (p<0.05) in HDL level (75.0 ± 1.7 mg/dL) and SOD (74.6 ± 2.1 unit/mL). Conclusions: Lissachatina fulica chitosan can reduce total cholesterol, triglyceride, LDL, and MDA, and increase HDL and SOD levels. 
546 |a EN 
546 |a ES 
690 |a hypercholesterolemia 
690 |a lipid profile 
690 |a lissachatina fulica chitosan 
690 |a mda 
690 |a sod 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Journal of Pharmacy & Pharmacognosy Research, Vol 10, Iss 6, Pp 995-1005 (2022) 
787 0 |n https://jppres.com/jppres/pdf/vol10/jppres22.1468_10.6.995.pdf 
787 0 |n https://doaj.org/toc/0719-4250 
856 4 1 |u https://doaj.org/article/e99100e58db64dda9f578b8c3d19a9c7  |z Connect to this object online.